Amsurg (AMSG) Showing Signs Of Being Strong And Under The Radar
at The Street - Fri Dec 19, 10:52AM CST
Trade-Ideas LLC identified Amsurg (AMSG) as a strong and under the radar candidate
AMSG: 54.43 (+0.41)
Barbarian At The Gate: Amsurg (AMSG)
at The Street - Thu Dec 18, 2:12PM CST
Trade-Ideas LLC identified Amsurg (AMSG) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
AMSG: 54.43 (+0.41)
United States Outpatient Care Centers Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts - Market to reach $169.3 billion by 2021
M2 - Mon Dec 15, 8:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/wxgmv7/outpatient_care) has announced the addition of Plunkett Research Ltd's new report "Outpatient Care Centers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Outpatient Care Centers Industry (U.S.) to reach $169.3 billion by 2021 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked - Advanzeon Solutions Inc - AmSurg Corp - DaVita Healthcare Partners Inc - Dynacq Healthcare Inc - Fresenius Medical Care Holdings Inc - Graymark Healthcare Inc - IntegraMed America Inc - LCA-Vision Inc - United Surgical Partners International Inc For more information visit http://www.researchandmarkets.com/research/wx...tient_care Source: Plunkett Research Ltd
LCAV: 5.37 (unch), AMSG: 54.43 (+0.41)
Insider Trading Alert - HFWA, AMSG And MHR Traded By Insiders
at The Street - Fri Dec 05, 10:00AM CST
Stocks with insider trader activity include HFWA, AMSG and MHR
AMSG: 54.43 (+0.41), MHR: 3.34 (-0.02), HFWA: 17.62 (+0.18)
Gentiva's (GTIV) Inorganic Growth Strategies Look Impressive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 01, 2:10PM CST
On Nov 27, 2014, we issued an updated research report on Gentiva Health Services Inc. (GTIV).
KND: 18.21 (+0.11), AMSG: 54.43 (+0.41), AFAM: 29.53 (-0.06), GTIV: 19.07 (unch)
The Long Case For AmSurg
Mike Greenwood - at Seeking Alpha - Fri Nov 28, 3:50PM CST
( Editors' Note: This article was submitted in October as an entry in the Harvard /Seeking Alpha Stock-pitching competition held on Nov. 8, 2014). By Alex Hong , Mike Greenwood , Sparsh Shah , Kevin Xo , and Western Capital Markets ...
AMSG: 54.43 (+0.41)
AmSurg Corp. to Present at the Bank of America Merrill Lynch 2014 Leveraged Finance Conference
Business Wire - Tue Nov 25, 10:00AM CST
AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Bank of America Merrill Lynch 2014 Leveraged Finance Conference on Tuesday, December 2, 2014, in Boca Raton, Florida. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 8:10 a.m. Eastern Time / 7:10 a.m. Central Time. Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President and Chief Financial Officer, will be speaking at the conference.
AMSG: 54.43 (+0.41)
AmSurg Declares Quarterly Preferred Stock Dividend
Business Wire - Tue Nov 25, 6:00AM CST
AmSurg Corp. (NASDAQ: AMSG) today announced that its Board of Directors has declared a quarterly dividend of $1.3125 per share in cash for the Company's 5.250% Mandatory Convertible Preferred Stock, Series A-1. The dividend is payable on January 1, 2015 to shareholders of record as of December 15, 2014.
AMSG: 54.43 (+0.41)
Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Amsurg Is Down 2.9% (AMSG)
Comtex SmarTrend(R) - Mon Nov 24, 8:52AM CST
When Amsurg (NASDAQ:AMSG) reported earnings 20 days ago on November 4th, 2014, analysts, on average, expected the company to report earnings of $0.64 on sales of $515.1 million. Amsurg actually reported earnings of $0.69 per share on sales of $503.2 million, beating EPS estimates by $0.05 and missing revenue estimates by $11.9 million. Shares of Amsurg have slipped from $52.28 to $50.78, representing a loss of 2.9%, since the company reported earnings 20 days ago.
AMSG: 54.43 (+0.41)
Zacks Rank #1 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
AMSG: 54.43 (+0.41), AGN: 210.12 (+0.95), AMSF: 42.19 (+0.07), AEL: 28.73 (+0.12), TWOU: 19.44 (-0.18)
Can AmSurg (AMSG) Stock Continue to Grow Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 7:47AM CST
AmSurg (AMSG) might be well-positioned for future earnings growth. This firm saw EPS growth of 12.6% last year, and is looking great for this year too. The current growth estimate for this year calls for earnings-per-share growth of 13.6%.
AMSG: 54.43 (+0.41)
Europe Ambulatory Surgical & Emergency Center Services (Pain Management, Ophthalmology, Gastrointestinal, Pulmonary, Dermatology, Vascular, Urology, ENT, Orthopedics, Obstetrics) Market - Forecast to 2020
M2 - Tue Nov 18, 4:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/87lvwp/europe_ambulatory) has announced the addition of the "Europe Ambulatory Surgical & Emergency Center Services Market: - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report to their offering. Ambulatory surgery is defined as surgical and diagnostic intervention that does not require overnight hospital stay. The ambulatory surgery has been increasingly adopted by patient population in Europe owing to its safe, high quality, cost-effective and time saving approach to perform surgical interventions. In addition, advancements in technologies that enables healthcare professionals to perform multiple minimally invasive surgical procedures in a single day further drives the market growth in Europe. For example, advent of minimally invasive surgeries such as laparoscopic procedures has permitted complex surgeries such as gallbladder, hysterectomy surgeries to be done in reduced amount of time. However, factors such as lack of adequate medical facilities and favorable reimbursement policies for inpatient surgeries as compared to outpatient surgeries might impede the growth of Europe ambulatory surgical and emergency center services market. In 2013, the orthopedic surgeries segment accounted for the largest share. Dominance of this market segment was majorly due to high cost of procedures coupled with rising prevalence of arthroscopic procedures. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Europe Ambulatory Surgical & Emergency Center Services Market, by Types of Procedure Chapter 5 Europe Ambulatory Surgical & Emergency Center Services Market, by Country Chapter 6 Competitive Landscape Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - AmSurg Corp. - Community Health Systems, Inc. - Eifelh?hen Klinik AG - Healthway Medical Group - IntegraMed America, Inc. - LCA - Vision, Inc. - Medical Facilities Corporation - Nueterra - Surgery Partners - Symbion, Inc. - Terveystalo Healthcare Oyj For more information visit http://www.researchandmarkets.com/research/87...ambulatory
AMSG: 54.43 (+0.41), CYH: 55.36 (+0.37)
Amsurg Earnings In Retrospect: Down 4.4% in the Last 13 Days (AMSG)
Comtex SmarTrend(R) - Mon Nov 17, 12:57PM CST
13 days ago, on November 4th, 2014, Amsurg (NASDAQ:AMSG) reported its earnings. Analysts, on average, expected earnings of $0.64 per share on sales of $515.1 million. Amsurg actually reported earnings of $0.69 per share on sales of $503.2 million, beating EPS estimates by $0.05 and missing revenue estimates by $11.9 million. Since the company's report, shares of Amsurg have fallen from $52.28 to $50.00, representing a loss of 4.4% in the past 13 days.
AMSG: 54.43 (+0.41)
Watch for Amsurg to Potentially Rebound After Falling 2.30% Yesterday
Comtex SmarTrend(R) - Tue Nov 11, 4:17PM CST
Amsurg (NASDAQ:AMSG) traded in a range yesterday that spanned from a low of $49.63 to a high of $50.94. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $50.82 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AMSG: 54.43 (+0.41)
AmSurg Corp. Announces Sale of Common Stock by Affiliates of Hellman & Friedman LLC
Business Wire - Mon Nov 10, 3:30PM CST
AmSurg Corp. (the "Company"
AMSG: 54.43 (+0.41)
Amsurg's Q3 Earnings Top on Revenue Growth, View Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 11:20AM CST
Amsurg Corp. (AMSG) reported third-quarter 2014 adjusted earnings per share (EPS) of 66 cents from continuing operations.
CHE: 106.16 (+0.13), AMSG: 54.43 (+0.41), RDNT: 9.41 (-0.08), AMED: 28.97 (-0.08)
AmSurg's (AMSG) CEO Christopher Holden on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 8:10PM CST
AMSG: 54.43 (+0.41)
Amsurg reports 3Q loss
Automated Insights - Tue Nov 04, 4:09PM CST
NASHVILLE, Tenn. (AP) _ Amsurg Corp. (AMSG) on Tuesday reported a loss of $9.8 million in its third quarter.
AMSG: 54.43 (+0.41)
Amsurg (AMSG) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 3:55PM CST
AMSG: 54.43 (+0.41)
Amsurg beats by $0.11, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 3:25PM CST
AMSG: 54.43 (+0.41)